Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

527 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal.
Turajlic S, Xu H, Litchfield K, Rowan A, Horswell S, Chambers T, O'Brien T, Lopez JI, Watkins TBK, Nicol D, Stares M, Challacombe B, Hazell S, Chandra A, Mitchell TJ, Au L, Eichler-Jonsson C, Jabbar F, Soultati A, Chowdhury S, Rudman S, Lynch J, Fernando A, Stamp G, Nye E, Stewart A, Xing W, Smith JC, Escudero M, Huffman A, Matthews N, Elgar G, Phillimore B, Costa M, Begum S, Ward S, Salm M, Boeing S, Fisher R, Spain L, Navas C, Grönroos E, Hobor S, Sharma S, Aurangzeb I, Lall S, Polson A, Varia M, Horsfield C, Fotiadis N, Pickering L, Schwarz RF, Silva B, Herrero J, Luscombe NM, Jamal-Hanjani M, Rosenthal R, Birkbak NJ, Wilson GA, Pipek O, Ribli D, Krzystanek M, Csabai I, Szallasi Z, Gore M, McGranahan N, Van Loo P, Campbell P, Larkin J, Swanton C; TRACERx Renal Consortium. Turajlic S, et al. Among authors: pickering l. Cell. 2018 Apr 19;173(3):595-610.e11. doi: 10.1016/j.cell.2018.03.043. Epub 2018 Apr 12. Cell. 2018. PMID: 29656894 Free PMC article.
Adjuvant aromatase inhibitors and bone health.
Chowdhury S, Pickering LM, Ellis PA. Chowdhury S, et al. J Br Menopause Soc. 2006 Sep;12(3):97-103. doi: 10.1258/136218006778234020. J Br Menopause Soc. 2006. PMID: 16953982 Review.
A phase I/II trial of sorafenib and infliximab in advanced renal cell carcinoma.
Larkin JM, Ferguson TR, Pickering LM, Edmonds K, James MG, Thomas K, Banerji U, Berns B, de Boer C, Gore ME. Larkin JM, et al. Among authors: pickering lm. Br J Cancer. 2010 Oct 12;103(8):1149-53. doi: 10.1038/sj.bjc.6605889. Epub 2010 Sep 14. Br J Cancer. 2010. PMID: 20842130 Free PMC article. Clinical Trial.
Sunitinib for metastatic renal cell carcinoma.
Mukherji D, Larkin J, Pickering L. Mukherji D, et al. Among authors: pickering l. Future Oncol. 2010 Sep;6(9):1377-85. doi: 10.2217/fon.10.94. Future Oncol. 2010. PMID: 20919823 Review.
A prospective study of chemotherapy-induced febrile neutropenia in the South West London Cancer Network. Interpretation of study results in light of NCAG/NCEPOD findings.
Okera M, Chan S, Dernede U, Larkin J, Popat S, Gilbert D, Jones L, Osuji N, Sykes H, Oakley C, Pickering L, Lofts F, Chowdhury S. Okera M, et al. Among authors: pickering l. Br J Cancer. 2011 Feb 1;104(3):407-12. doi: 10.1038/sj.bjc.6606059. Epub 2010 Dec 21. Br J Cancer. 2011. PMID: 21179036 Free PMC article.
527 results